Gene interactions and pathways from curated databases and text-mining
Cancer Lett 2011, PMID: 22055460

TSC1/TSC2 inactivation inhibits AKT through mTORC1-dependent up-regulation of STAT3-PTEN cascade.

Zha, Xiaojun; Hu, Zhongdong; He, Shaozong; Wang, Fang; Shen, Huangxuan; Zhang, Hongbing

Aberrant activation of mammalian target of rapamycin complex 1 (mTORC1), caused by loss or inactivation of TSC1/TSC2 protein complex, leads to negative feedback inhibition of Akt. The exact mechanisms of this process are still not fully understood. Here we present evidence for the involvement of STAT3, a known mTORC1 regulated transcription factor, in this process. We demonstrate that STAT3 promotes the transcription of PTEN by directly binding on the PTEN promoter. Elevated PTEN then inhibits the proliferation of Tsc1(-/-) or Tsc2(-/-) cells through down-regulation of Akt signaling. Activation of PTEN in this pathway may thus serve as a protective mechanism against hyper-activated mTORC1 mediated tumorigenesis and contribute to the benign nature of tumors caused by loss of either TSC1 or TSC2.

Diseases/Pathways annotated by Medline MESH: Cell Transformation, Neoplastic
Document information provided by NCBI PubMed

Text Mining Data

Akt ⊣ mammalian target of rapamycin: " Aberrant activation of mammalian target of rapamycin complex 1 ( mTORC1 ), caused by loss or inactivation of TSC1/TSC2 protein complex, leads to negative feedback inhibition of Akt "

transcription factor — mTORC1: " Here we present evidence for the involvement of STAT3, a known mTORC1 regulated transcription factor , in this process "

Manually curated Databases

No curated data.